Albertson’s LLC opens pharmacy inside California hospital
FULLERTON, Calif. — Albertson’s LLC, which operates Sav-On Pharmacies, opened last week a Sav-On Pharmacy by Albertsons inside Palomar Medical Center.
Located just inside the lobby of the new medical center, the 2,200 sq-ft Sav-On Pharmacy, which includes a Starbucks, is the first location of its kind to be built in a hospital in California.
Patients can have their prescriptions filled before going home, and visitors can peruse and purchase a variety of gifts, including jewelry and reading materials, or even pick up last-minute grocery items. The gift shop also carries fresh floral arrangements, greeting cards and an assortment of restaurant and retail gift cards.
The attached Starbucks bistro-style location serves as the ideal place for some quiet time in a tranquil setting that overlooks a healing garden.
“At Palomar Health, the patient experience extends well beyond the walls of the hospital room,” stated chief administrative officer Gerald Bracht. “Partnering with our friends at Albertsons was a natural fit because they embody customer service and offer the added comfort and convenience our patients and guests deserve. These services will simply enhance the total experience at Palomar Medical Center.”
“As the grand opening nears, we’re even more excited to welcome our customers. This is a new business opportunity for us and unlike any conventional store we’ve ever operated,” added Sav-On divisional pharmacy manager Perry Brown.
In celebration of the partnership forged with Palomar Medical Center, a donation will be pledged to the Palomar Health Foundation.
Drug take-back programs draw praise
WASHINGTON — The last six drug take-back days sponsored by the Drug Enforcement Agency have collected nearly 2.8 million pounds of prescription drugs at more than 5,800 sites across the country, drawing praise from a drug industry trade organization.
The Generic Pharmaceutical Association said it "strongly supports" the DEA’s efforts, including the seventh annual National Prescription Drug Take-Back Day, which took place Saturday.
"The DEA’s National Prescription Take-Back Day program is an excellent example of options for safe and accessible drug disposal available for patients," GPhA president and CEO Ralph Neas said. "While it is critical for every patient to take drugs as directed, it also is important for patients to dispose of unused medicines properly. With thousands of local fire stations, schools and law-enforcement departments participating, National Prescription Take-Back Day offers a simple, dependable way for consumers to find a local disposal site and drop off unused medications."
Many retailers also took part in the event, with Ahold USA and CVS/pharmacy highlighting their efforts.
Depomed launches Lazanda nasal spray for breakthrough pain in cancer patients
NEWARK, Calif. — Depomed has launched a new drug for breakthrough pain in cancer patients, the company said Monday.
The drug maker announced the launch of Lazanda (fentanyl) nasal spray, meant for treating adults who are taking opioid painkillers, but have become tolerant to them. The company also have launched a Signature Support Program designed to streamline patient access to the drug, including reimbursement and co-pay assistance. Other benefits of the program include prescription reminders and eligibility for one month’s supply for free.
"Breakthrough pain is very common among cancer patients and can be properly managed to reduce the number and severity of episodes and the interference of daily activities," University of Arizona anesthesiology professor Emil Annabi said. "Studies show that breakthrough pain is associated with poorer function and higher cost of care, which is why cancer patients need support services so they can focus on getting pain relief and not be troubled by reimbursement and access issues."